Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Promoting Optimal Development: Identifying Infants and Young Children With Developmental Disorders Through Developmental Surveillance and Screening.

Lipkin PH, Macias MM; COUNCIL ON CHILDREN WITH DISABILITIES, SECTION ON DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS.

Pediatrics. 2020 Jan;145(1). pii: e20193449. doi: 10.1542/peds.2019-3449. Epub 2019 Dec 16.

PMID:
31843861
2.

Epilepsy and Autism Severity: A Study of 6,975 Children.

Ewen JB, Marvin AR, Law K, Lipkin PH.

Autism Res. 2019 Aug;12(8):1251-1259. doi: 10.1002/aur.2132. Epub 2019 May 24.

PMID:
31124277
3.

Elopement Patterns and Caregiver Strategies.

Andersen AM, Law JK, Marvin AR, Lipkin PH.

J Autism Dev Disord. 2019 Mar 5. doi: 10.1007/s10803-019-03961-x. [Epub ahead of print]

PMID:
30838492
4.

Anxiety and Mood Disorder in Children With Autism Spectrum Disorder and ADHD.

Gordon-Lipkin E, Marvin AR, Law JK, Lipkin PH.

Pediatrics. 2018 Apr;141(4). pii: e20171377. doi: 10.1542/peds.2017-1377.

5.

Large Databases for Pediatric Research on Children with Autism Spectrum Disorder.

Kuhlthau KA, Bailey LC, Baer BL, Coury DL, Law JK, Murray DS, Razzaghi H, Forrest CB, Lipkin PH.

J Dev Behav Pediatr. 2018 Feb/Mar;39(2):168-176. doi: 10.1097/DBP.0000000000000534.

PMID:
29239865
6.

Analysis of Social Communication Questionnaire (SCQ) Screening for Children Less Than Age 4.

Marvin AR, Marvin DJ, Lipkin PH, Law JK.

Curr Dev Disord Rep. 2017;4(4):137-144. doi: 10.1007/s40474-017-0122-1. Epub 2017 Nov 4. Review.

7.

Adolescent Perceptions of Outgrowing Childhood Attention-Deficit Hyperactivity Disorder: Relationship to Symptoms and Quality of Life.

Anixt JS, Vaughn AJ, Powe NR, Lipkin PH.

J Dev Behav Pediatr. 2016 Apr;37(3):196-204. doi: 10.1097/DBP.0000000000000279.

PMID:
26950341
8.

The Individuals With Disabilities Education Act (IDEA) for Children With Special Educational Needs.

Lipkin PH, Okamoto J; Council on Children with Disabilities; Council on School Health.

Pediatrics. 2015 Dec;136(6):e1650-62. doi: 10.1542/peds.2015-3409.

9.

Characterizing the daily life, needs, and priorities of adults with autism spectrum disorder from Interactive Autism Network data.

Gotham K, Marvin AR, Taylor JL, Warren Z, Anderson CM, Law PA, Law JK, Lipkin PH.

Autism. 2015 Oct;19(7):794-804. doi: 10.1177/1362361315583818. Epub 2015 May 11.

10.

A Genetic Multimutation Model of Autism Spectrum Disorder Fits Disparate Twin Concordance Data from the USA and Canada.

Kramer I, Lipkin PH, Marvin AR, Law PA.

Int Sch Res Notices. 2015 Mar 4;2015:519828. doi: 10.1155/2015/519828. eCollection 2015.

11.

Methylphenidate reduces ADHD symptoms in children with severe ADHD and intellectual disability.

Lipkin PH.

Evid Based Ment Health. 2013 Nov;16(4):104. doi: 10.1136/eb-2013-101454. Epub 2013 Aug 30. No abstract available.

PMID:
23996111
12.

Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association.

Marino BS, Lipkin PH, Newburger JW, Peacock G, Gerdes M, Gaynor JW, Mussatto KA, Uzark K, Goldberg CS, Johnson WH Jr, Li J, Smith SE, Bellinger DC, Mahle WT; American Heart Association Congenital Heart Defects Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing, and Stroke Council.

Circulation. 2012 Aug 28;126(9):1143-72. Epub 2012 Jul 30.

PMID:
22851541
13.

Lessons and opportunities from autism screening in high-risk children.

Lipkin PH.

Dev Med Child Neurol. 2012 Jun;54(6):485. doi: 10.1111/j.1469-8749.2012.04285.x. Epub 2012 Mar 28. No abstract available.

14.

Should all children be screened for autism spectrum disorders? Yes: merging science, policy, and practice.

Lipkin PH, Hyman SL.

Am Fam Physician. 2011 Aug 15;84(4):361-7. No abstract available.

15.

Using systematic reviews and meta-analyses to support regulatory decision making for neurotoxicants: lessons learned from a case study of PCBs.

Goodman M, Squibb K, Youngstrom E, Anthony LG, Kenworthy L, Lipkin PH, Mattison DR, LaKind JS.

Cien Saude Colet. 2011 Jul;16(7):3207-20. Review.

16.

Learning disabilities and school failure.

Rimrodt SL, Lipkin PH.

Pediatr Rev. 2011 Aug;32(8):315-24. doi: 10.1542/pir.32-8-315. Review.

PMID:
21807872
17.

A proposal to facilitate weight-of-evidence assessments: Harmonization of Neurodevelopmental Environmental Epidemiology Studies (HONEES).

Youngstrom E, Kenworthy L, Lipkin PH, Goodman M, Squibb K, Mattison DR, Anthony LG, Makris SL, Bale AS, Raffaele KC, LaKind JS.

Neurotoxicol Teratol. 2011 May-Jun;33(3):354-9. doi: 10.1016/j.ntt.2011.01.004. Epub 2011 Feb 18.

18.

Advancing the selection of neurodevelopmental measures in epidemiological studies of environmental chemical exposure and health effects.

Youngstrom E, LaKind JS, Kenworthy L, Lipkin PH, Goodman M, Squibb K, Mattison DR, Anthony BJ, Anthony LG.

Int J Environ Res Public Health. 2010 Jan;7(1):229-68. doi: 10.3390/ijerph7010229. Epub 2010 Jan 19.

19.

Using systematic reviews and meta-analyses to support regulatory decision making for neurotoxicants: lessons learned from a case study of PCBs.

Goodman M, Squibb K, Youngstrom E, Anthony LG, Kenworthy L, Lipkin PH, Mattison DR, Lakind JS.

Environ Health Perspect. 2010 Jun;118(6):727-34. doi: 10.1289/ehp.0901835. Epub 2010 Feb 22.

20.

Implementing developmental screening and referrals: lessons learned from a national project.

King TM, Tandon SD, Macias MM, Healy JA, Duncan PM, Swigonski NL, Skipper SM, Lipkin PH.

Pediatrics. 2010 Feb;125(2):350-60. doi: 10.1542/peds.2009-0388. Epub 2010 Jan 25.

PMID:
20100754
21.

Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM.

Mohamadi A, Clark LM, Lipkin PH, Mahone EM, Wodka EL, Plotnick LP.

Pediatr Diabetes. 2010 May;11(3):203-7. doi: 10.1111/j.1399-5448.2009.00548.x. Epub 2009 Jul 21.

PMID:
19686306
22.

Promoting reading in children: do reading practices differ in children with developmental problems?

Butz AM, Crocetti M, Thompson RE, Lipkin PH.

Clin Pediatr (Phila). 2009 Apr;48(3):275-83. doi: 10.1177/0009922808327054. Epub 2008 Nov 20.

PMID:
19023108
23.

The thorny nature of predictive validity studies on screening tests for developmental-behavioral problems.

Marks K, Glascoe FP, Aylward GP, Shevell MI, Lipkin PH, Squires JK.

Pediatrics. 2008 Oct;122(4):866-8. doi: 10.1542/peds.2007-3142. Review. No abstract available.

PMID:
18829812
24.

Improving developmental screening: combining parent and pediatrician opinions with standardized questionnaires.

Lipkin PH, Gwynn H.

Pediatrics. 2007 Mar;119(3):655-6; author reply 656-7. No abstract available.

PMID:
17332228
25.

Attitudes about stimulant medication for attention-deficit/hyperactivity disorder among African American families in an inner city community.

dosReis S, Butz A, Lipkin PH, Anixt JS, Weiner CL, Chernoff R.

J Behav Health Serv Res. 2006 Oct;33(4):423-30.

PMID:
17078011
26.

Hershey Medical Center Technical Workshop Report: optimizing the design and interpretation of epidemiologic studies for assessing neurodevelopmental effects from in utero chemical exposure.

Amler RW, Barone S Jr, Belger A, Berlin CM Jr, Cox C, Frank H, Goodman M, Harry J, Hooper SR, Ladda R, LaKind JS, Lipkin PH, Lipsitt LP, Lorber MN, Myers G, Mason AM, Needham LL, Sonawane B, Wachs TD, Yager JW.

Neurotoxicology. 2006 Sep;27(5):861-74. Epub 2006 Jul 21. Review.

27.

Stimulant dosage and age, race, and insurance type in a sample of children with attention-deficit/hyperactivity disorder.

Lipkin PH, Cozen MA, Thompson RE, Mostofsky SH.

J Child Adolesc Psychopharmacol. 2005 Apr;15(2):240-8.

PMID:
15910208
28.

Introduction: developmental assessment of the fetus and young infant.

Allen MC, Lipkin PH.

Ment Retard Dev Disabil Res Rev. 2005;11(1):1-2. No abstract available.

PMID:
15856449
29.

Towards creation of a unified view of the neurodevelopment of the infant.

Lipkin PH.

Ment Retard Dev Disabil Res Rev. 2005;11(1):103-6.

PMID:
15856437
30.

High-dose methylphenidate treatment of attention deficit hyperactivity disorder in a preschooler.

Lipkin PH, Butz AM, Cozen MA.

J Child Adolesc Psychopharmacol. 2003 Spring;13(1):103-6.

PMID:
12804131
31.

Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide.

Lipkin PH, Davidson D, Spivak L, Straube R, Rhines J, Chang CT.

J Pediatr. 2002 Mar;140(3):306-10.

PMID:
11953727
32.

Ocular injury from a rooster attack.

Kronwith SD, Hankin DE, Lipkin PH.

Clin Pediatr (Phila). 1996 Apr;35(4):219-20. Review. No abstract available.

PMID:
8665758
33.

Tics and dyskinesias associated with stimulant treatment in attention-deficit hyperactivity disorder.

Lipkin PH, Goldstein IJ, Adesman AR.

Arch Pediatr Adolesc Med. 1994 Aug;148(8):859-61.

PMID:
8044265
34.

Early outcome determination of low-birth-weight infants using the Neurodevelopmental Risk Examination.

Lipkin PH, Altshuler LA.

Clin Pediatr (Phila). 1994 Jul;33(7):398-403.

PMID:
7525136
35.

Otitis media in children with learning disabilities and in children with attention deficit disorder with hyperactivity.

Adesman AR, Altshuler LA, Lipkin PH, Walco GA.

Pediatrics. 1990 Mar;85(3 Pt 2):442-6.

PMID:
2304807
36.

A case of glutaric acidemia type I: effect of riboflavin and carnitine.

Lipkin PH, Roe CR, Goodman SI, Batshaw ML.

J Pediatr. 1988 Jan;112(1):62-5. No abstract available.

PMID:
3335963

Supplemental Content

Loading ...
Support Center